162 related articles for article (PubMed ID: 17401461)
1. Gene expression profiling of chemically induced rat bladder tumors.
Yao R; Yi Y; Grubbs CJ; Lubet RA; You M
Neoplasia; 2007 Mar; 9(3):207-21. PubMed ID: 17401461
[TBL] [Abstract][Full Text] [Related]
2. Altered gene expression profile in mouse bladder cancers induced by hydroxybutyl(butyl)nitrosamine.
Yao R; Lemon WJ; Wang Y; Grubbs CJ; Lubet RA; You M
Neoplasia; 2004; 6(5):569-77. PubMed ID: 15548366
[TBL] [Abstract][Full Text] [Related]
3. Modulation of gene expression and cell-cycle signaling pathways by the EGFR inhibitor gefitinib (Iressa) in rat urinary bladder cancer.
Lu Y; Liu P; Van den Bergh F; Zellmer V; James M; Wen W; Grubbs CJ; Lubet RA; You M
Cancer Prev Res (Phila); 2012 Feb; 5(2):248-59. PubMed ID: 21982874
[TBL] [Abstract][Full Text] [Related]
4. Identification of differently expressed genes in chemical carcinogen-induced rat bladder cancers.
Chen G; Chan FL; Zhang X; Chan PS
J Huazhong Univ Sci Technolog Med Sci; 2009 Apr; 29(2):220-6. PubMed ID: 19399409
[TBL] [Abstract][Full Text] [Related]
5. H-ras activation and ras p21 expression in bladder tumors induced in F344/NCr rats by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Enomoto T; Ward JM; Perantoni AO
Carcinogenesis; 1990 Dec; 11(12):2233-8. PubMed ID: 2265474
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation.
Lee CC; Yamamoto S; Wanibuchi H; Wada S; Sugimura K; Kishimoto T; Fukushima S
Cancer Res; 1997 Nov; 57(21):4765-76. PubMed ID: 9354438
[TBL] [Abstract][Full Text] [Related]
7. Transgenic rats carrying copies of the human c-Ha-ras proto-oncogene exhibit enhanced susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis.
Ota T; Asamoto M; Toriyama-Baba H; Yamamoto F; Matsuoka Y; Ochiya T; Sekiya T; Terada M; Akaza H; Tsuda H
Carcinogenesis; 2000 Jul; 21(7):1391-6. PubMed ID: 10874018
[TBL] [Abstract][Full Text] [Related]
8. p53 mutations in early neoplastic lesions of the urinary bladder in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Masui T; Don I; Takada N; Ogawa K; Shirai T; Fukushima S
Carcinogenesis; 1994 Oct; 15(10):2379-81. PubMed ID: 7955081
[TBL] [Abstract][Full Text] [Related]
9. Activation of H-ras oncogene in rat bladder tumors induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Fujita J; Ohuchi N; Ito N; Reynolds SH; Yoshida O; Nakayama H; Kitamura Y
J Natl Cancer Inst; 1988 Mar; 80(1):37-43. PubMed ID: 3276902
[TBL] [Abstract][Full Text] [Related]
10. Molecular credentialing of rodent bladder carcinogenesis models.
Williams PD; Lee JK; Theodorescu D
Neoplasia; 2008 Aug; 10(8):838-46. PubMed ID: 18670642
[TBL] [Abstract][Full Text] [Related]
11. Absence of ras oncogene activation in rat urinary bladder carcinomas induced by N-methyl-N-nitrosourea or N-butyl-N-(4-hydroxybutyl)nitrosamine.
Masui T; Mann AM; Macatee TL; Okamura T; Garland EM; Smith RA; Cohen SM
Carcinogenesis; 1992 Dec; 13(12):2281-5. PubMed ID: 1473235
[TBL] [Abstract][Full Text] [Related]
12. LOH and mutational analysis of p53 alleles in mouse urinary bladder carcinomas induced by N-butyl-N-(4-hydroxybutyl) nitrosamine.
Morimura K; Yamamoto S; Murai T; Mori S; Chen TX; Wanibuchi H; Fukushima S
Carcinogenesis; 1999 Apr; 20(4):715-8. PubMed ID: 10223204
[TBL] [Abstract][Full Text] [Related]
13. Loss of heterozygosity in (LewisxF344)F1 rat urinary bladder tumors induced with N-butyl-N-(4-hydroxybutyl)nitrosamine followed by dimethylarsinic acid or sodium L-ascorbate.
Chen T; Na Y; Wanibuchi H; Yamamoto S; Lee CC; Fukushima S
Jpn J Cancer Res; 1999 Aug; 90(8):818-23. PubMed ID: 10543252
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of the EGFr inhibitor Iressa on development of chemically-induced urinary bladder cancers: dose dependency and modulation of biomarkers.
Lubet RA; Lu Y; Bode AM; You M; Verney ZM; Steele VE; Townsend R; Juliana MM; Grubbs CJ
Oncol Rep; 2011 May; 25(5):1389-97. PubMed ID: 21369704
[TBL] [Abstract][Full Text] [Related]
15. Direct DNA sequencing of the rat neu oncogene transmembrane domain reveals no mutation in urinary bladder carcinomas induced by N-butyl-N-(4-hydroxybutyl)nitrosamine, N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide or N-methyl-N-nitrosourea.
Masui T; Mann AM; Macatee TL; Garland EM; Okamura T; Smith RA; Cohen SM
Carcinogenesis; 1991 Oct; 12(10):1975-8. PubMed ID: 1682063
[TBL] [Abstract][Full Text] [Related]
16. Frequent mutations of the p53 gene and infrequent H- and K-ras mutations in urinary bladder carcinomas of NON/Shi mice treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Yamamoto S; Masui T; Murai T; Mori S; Oohara T; Makino S; Fukushima S; Tatematsu M
Carcinogenesis; 1995 Oct; 16(10):2363-8. PubMed ID: 7586136
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation adduct formation and H-ras gene mutations in progression of N-butyl-N-(4-hydroxybutyl)nitrosamine-induced bladder tumors caused by a single exposure to N-methyl-N-nitrosourea.
Shibata MA; Shirai T; Ogawa K; Takahashi S; Wild CP; Montesano R; Tsuda H; Ito N
Carcinogenesis; 1994 Dec; 15(12):2965-8. PubMed ID: 8001265
[TBL] [Abstract][Full Text] [Related]
18. Expression of S100 protein family members in the pathogenesis of bladder tumors.
Yao R; Lopez-Beltran A; Maclennan GT; Montironi R; Eble JN; Cheng L
Anticancer Res; 2007; 27(5A):3051-8. PubMed ID: 17970044
[TBL] [Abstract][Full Text] [Related]
19. Gene expression in the bladder carcinoma rat model.
Ariel I; Ayesh S; Gofrit O; Ayesh B; Abdul-Ghani R; Pizov G; Smith Y; Sidi AA; Birman T; Schneider T; de Groot N; Hochberg A
Mol Carcinog; 2004 Oct; 41(2):69-76. PubMed ID: 15378645
[TBL] [Abstract][Full Text] [Related]
20. Involvement of epidermal growth factor receptor in chemically induced mouse bladder tumour progression.
el-Marjou A; Delouvée A; Thiery JP; Radvanyi F
Carcinogenesis; 2000 Dec; 21(12):2211-8. PubMed ID: 11133810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
